UnicoCell Biomed CO. LTD
Quick facts
Phase 3 pipeline
- ELIXCYTE · Oncology
ELIXCYTE is an autologous cell therapy that expands and reinfuses a patient's own immune cells to enhance anti-tumor immunity.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: